Multiple myeloma | Nature Reviews Disease Primers
Multiple Myeloma Clinical Trials
Multiple Myeloma Support + Trials
Vincent Rajkumar on Twitter: "Here is the management approach to MGUS. Uncomplicated patients with low risk MGUS do not need a baseline bone marrow or bone survey, and don't need annual follow
Changing paradigms in diagnosis and treatment of monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM) | Leukemia
Treatment of Smoldering Myeloma Delays Disease Progression, Yet Questions Remain
The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network | Haematologica
New IMWG Criteria Reflect Change in Practice - Clinical Oncology News
Screening for Monoclonal Gammopathy of Undetermined Significance: First Results from the iStopMM Study
Future Directions in the Evaluation and Treatment of Precursor Plasma Cell Disorders | American Society of Clinical Oncology Educational Book
MC Community Event: Clinical Trials for High Risk Smoldering Myeloma Patients
Clinical and biological characteristics of MGUS and SMM patients... | Download Table
Demographic and clinical data (mean values) for patients with MGUS and... | Download Table
Clinical trials of bisphosphonates in multiple myeloma. | Semantic Scholar
Is There a Link Between Monoclonal Gammopathy of Undetermined Significance and Familial Risk? — Diverse Health Hub
What is the significance of monoclonal gammopathy of undetermined significance? | RCP Journals
CRO Perspectives: Driving Innovation, Consistency and Reliability in Multiple Myeloma Clinical Trials - Insights From Our Labs to Yours
Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and randomized controlled trial of follow-up strategies | Blood Cancer Journal
Treatment Strategies for Patients with Multiple Myeloma: from Clinical Trials to Real Life | Frontiers Research Topic
Cancers | Free Full-Text | Monoclonal Gammopathy of Undetermined Significance (MGUS)—Not So Asymptomatic after All | HTML
Future Directions in the Evaluation and Treatment of Precursor Plasma Cell Disorders | American Society of Clinical Oncology Educational Book
Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology
INSIGHT MM: a large, global, prospective, non-interventional, real-world study of patients with multiple myeloma | Future Oncology
PLOS Medicine: Bone marrow microenvironments that contribute to patient outcomes in newly diagnosed multiple myeloma: A cohort study of patients in the Total Therapy clinical trials
MGUS Clinical Trials
Table 2 from Monoclonal gammopathy of undetermined significance. | Semantic Scholar
